Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer (GEMSTHER)

Blood Transfusion Centre of Slovenia

Status: Unknown

Conditions: Pancreatic Tubular Adenocarcinoma

Treatments: Other: Observation

Study type: Observational

Funder types: Other

Identifiers

NCT00947102

Gemcitabine1

Details and patient eligibility

About

Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.

Sex: All

Ages: 30 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ECOG performance status 0-2 at the time of inclusion
• Following R0 or R1 pancreatic tubular adenocarcinoma resection

Exclusion criteria

• Pregnancy
• Serious comorbidity

Trial design

0 participants in 1 patient group

Pancreatic tubular adenocarcinoma

Description:

Patients with pancreatic tubular adenocarcinoma

Treatment:

Other: Observation